Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017
The emergence of swine-origin pandemic H1N1 (pH1N1) in 2009 invigorated extensive surveillance programs worldwide which have resulted in the deposition of large numbers of H1N1 sequences to Genbank. In the present study, we report on global evolution and dynamics of the pandemic H1N1 influenza Hemagglutinin (HA) protein in viruses isolated from three different continents (North America, Europe and Asia) during the period between April 2009 until April 2017. Close to 2000 HA full protein sequences were downloaded from the Influenza Research Database of the NCBI and analyzed using DNAStar to run an alignment, the web-based NetNglyc to predict N-Glycosylation sites and finally, the BEAST software package to calculate evolution and substitution rates. Our analysis improves upon other published papers in that we report on frequencies, dynamics and impact of HA mutations in pH1N1 viruses isolated from three continents during the past decade, as well as the evolution rate and site-specific selection pressures. Sequence based analysis demonstrated substantial changes in the HA protein over the last decade. Results showed that the HA gene is under negative selection (P value; HA= -2.253). The evolution rates varied among the three continents ranging from 2.36 × 10−3 in Europe to 3.18 × 10−3 in Asia. Mutations were detected at higher frequency and faster rate at the antigenic sites surrounding the receptor-binding domain (RBD), in particular, in the Sa and Sb sites. Mutations were either gradually accumulated to become fixed in currently circulating strains (D114N, S179N, S202T, S220T, I233T, K300E and E391K) or dynamic in terms of appearance and disappearance, both spatially and temporally (A203T, N458K and E508G). Some of the reported mutations have been shown to increase infection severity (D239G/N; globular head), enhance HA binding affinity to its receptor (S200P and S202T; RBD), or have deleterious effect on HA function (N458K and E508G; stem region). The continuous accumulation of mutations at the Sa site led to the gradual acquisition of glycosylation at residue 179 starting from 2015, which became a dominant feature in all strains isolated in the following years. In addition to sharing common amino acid substitutions (e.g. S179N in HA head and E516K in HA stem) with previous seasonal strains, the pattern of glycosylation acquisition/loss at 177 and 179 positions on the globular head, which are prominent features of immune escape, implicate that pH1N1 might follow a similar evolution trend as the SC1918 pandemic virus.
Compliance with ethical standards
Conflict of interest
Authors declare no conflict of interest.
Availability of data and material
The datasets analysed during the current study are available in the in Influenza Research Database, https://www.fludb.org/.
- 1.Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA et al (2013) Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States, 9 Dec 2016. Available from: https://www.cdc.gov/flu/about/disease/2015-16.htm. Accessed 15 Mar 2018
- 3.WHO (2010) Pandemic (H1N1) 2009—update 112Google Scholar
- 4.WHO (2017) 21 August 2017,—Update number 296, based on data up to 06 August 2017. In: WHO report. WHOGoogle Scholar
- 8.World Health Organization (WHO) (2017) Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Available from: http://www.who.int/influenza/vaccines/virus/characteristics_virus_vaccines/en/. Accessed 11 Feb 2018
- 12.Job ER, Deng YM, Barfod KK, Tate MD, Caldwell N, Reddiex S, Maurer-Stroh S, Brooks AG, Reading PC (2013) Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses. J Immunol (Baltimore, Md : 1950) 190(5):2169–2177CrossRefGoogle Scholar
- 16.Influenza Research Database. https://www.fludb.org/. Accessed 20 Apr 2017
- 17.Influenza Research Database: https://www.fludb.org/. Accessed 20 April 2017
- 18.PROVEAN. http://provean.jcvi.org/. Accessed 25 Aug 2017
- 20.NetNGlyc 1.0 server: http://www.cbs.dtu.dk/. Accessed 20 July 2017
- 21.Gupta R, Brunak S (2002) Prediction of glycosylation across the human proteome and the correlation to protein function. In: Pacific Symposium on Biocomputing, vol 7. Bio-Centrum Technical University of Denmark, Lyngby, pp 310–322Google Scholar
- 29.de Vries RP, de Vries E, Martinez-Romero C, McBride R, van Kuppeveld FJ, Rottier PJ, Garcia-Sastre A, Paulson JC, de Haan CA (2013) Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol 87(24):13868–13877CrossRefPubMedPubMedCentralGoogle Scholar
- 30.World Health Organization-Vaccines (2017) WHO recommendations on the composition of influenza virus vaccines. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/en/. Accessed 27 Dec 2017
- 31.Jayaraman A, Pappas C, Raman R, Belser JA, Viswanathan K, Shriver Z, Tumpey TM, Sasisekharan R (2011) A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One 6(3):e17616CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, Caldwell N, Shaw R, Maurer-Stroh S (2010) A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Eur Surv 15(42):19692. https://doi.org/10.2807/ese.15.42.19692-en CrossRefGoogle Scholar